Daclatasvir + Sofosbuvir

Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying. And Daclatasvir is a direct-acting   antiviral agent (DAA) against the hepatitis C virus.

There are no products to list in this category.

Continue